The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -50.38%.However, over the last six months, we can see a stronger performance of -32.47%. Over the last 30 days, the price of PRAX has leaped by -42.91%. And in the last five days, it has fallen by -1.11%.
Praxis Precision Medicines Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $91.83 on 02/14/25 and the lowest value was $30.01 on 03/04/25.
52-week price history of PRAX Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Praxis Precision Medicines Inc’s current trading price is -58.41% away from its 52-week high, while its distance from the 52-week low is 27.26%. The stock’s price range during this period has varied between$30.01 and $91.83. The Praxis Precision Medicines Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.76 million for the day, a figure considerably higher than their average daily volume of 0.46 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Praxis Precision Medicines Inc (PRAX) has experienced a quarterly decline of -50.09% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 770.03M and boasts a workforce of 116 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 68.29, with a change in price of -32.84. Similarly, Praxis Precision Medicines Inc recorded 431,567 in trading volume during the last 100 days, posting a change of -46.23%.
PRAX’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PRAX stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
PRAX Stock Stochastic Average
Praxis Precision Medicines Inc’s raw stochastic average for the past 50 days is presently 13.23%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 21.05%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 18.13% and 17.10%, respectively.
